1. American Association for Geriatric Psychiatry, McLean, VA: Statement on Aducanumab, July 29, 2021, https://www.aagponline.org/index.php?src=news&srctype=detail&category=Press%20Releases&refno=137
2. Lerner KC: Madison memory study: a randomized, double-blind, placebo-controlled trial of apoaequorin in community-dwelling, older adults. Quincy Bioscience website, August 1, 2016. https://www.quincybioscience.com/research/
3. Apoaequorin for memory enhancement?;Hume;Pharmacy Today,2015
4. Bellamy J: Prevagen goes P-hacking. Science-Based Medicine, June 21, 2018. https://sciencebasedmedicine.org/prevagen-goes-p-hacking/
5. U.S. Food and Drug Administration, Minneapolis District Office: Warning letter, sent to Underwood MY, Quincy Bioscience Manufacturing Inc, Madison, WI. October 16, 2012. https://www.truthinadvertising.org/wp-content/uploads/2015/09/FDA-Warning-letter-10-16-12.pdf